Plerixafor in non-Hodgkin’s lymphoma and multiple myeloma patients undergoing autologous stem cell transplantation by Jan S. Moreb

Get full text

Cardiotoxicity due to targeted anticancer agents: a growing challenge by Chintan P. Shah, Jan S. Moreb

Get full text

COVID-19 in patients with acute leukemia: Two cases with different outcomes by Venkat Rajasurya, Kathleen Elliott, James Dugan, Jan S Moreb

Get full text

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study by Michael Byrne, Donya Salmasinia, Helen Leather, Christopher R. Cogle, Amy Davis, Jack W. Hsu, Laura Wiggins, Myron N. Chang, Qi An, John R. Wingard, Jan S. Moreb

Get full text

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study by Michael Byrne, Donya Salmasinia, Helen Leather, Christopher R. Cogle, Amy Davis, Jack W. Hsu, Laura Wiggins, Myron N. Chang, Qi An, John R. Wingard, Jan S. Moreb

Get full text

Lactate Dehydrogenase B and Pyruvate Oxidation Pathway Associated With Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients: Result of a Multi-Omics Integrative Analysis by Marwa Tantawy, Lakshmi Manasa Chekka, Yimei Huang, Timothy J. Garrett, Sonal Singh, Chintan P. Shah, Robert F. Cornell, Rachid C. Baz, Michael G. Fradley, Nida Waheed, David L. DeRemer, Lihui Yuan, Taimour Langaee, Taimour Langaee, Keith March, Carl J. Pepine, Jan S. Moreb, Yan Gong, Yan Gong, Yan Gong

Get full text